RIVM calls for increased involvement of scientific community in solving plastic crisis Industry and policymakers are not availing themselves enough of the available scientific knowledge when it comes to smarter ways of dealing with plastics.
Estimated costs of foodborne infections 140 million euros lower in 2020 In 2020, the estimated costs of foodborne infections in the Netherlands were 140 million euros lower than in the preceding year. This corresponds to a 30% decrease. ANP
Zoonoses Report 2020 focuses on emerging zoonoses The COVID-19 pandemic and the outbreak of the West Nile Virus in 2020 show that so-called emerging zoonoses pose a risk to the Netherlands. ANP
Sewage treatment workers not more likely to carry antibiotic-resistant bacteria Employees at sewage and wastewater treatment plants in the Netherlands and Germany are not more likely to carry antibiotic-resistant bacteria than other people. Unie van Waterschappen
Flu jab for additional groups The flu jab is offered free of charge every year to people aged 60 years and older, and to people who are at higher risk of becoming seriously ill from the flu virus due to medical reasons
Antimicrobial resistance in the Netherlands stable in 2020 In 2020, the year of the coronavirus SARS-CoV-2 pandemic, resistant bacteria were not found more often in patients in the Netherlands than before the outbreak.
Long-term symptoms more common after Lyme disease More than a quarter of people with Lyme disease continue to have long-term symptoms that lead to limitations in daily life even after treatment.
Method for safe and sustainable recycling of waste The method developed by RIVM to assess whether waste treatment is sufficiently safe and sustainable, can contribute to the European ambitions for a safe and more circular economy.
Last winter’s flu epidemic was short and mild. And then COVID-19 arrived. The flu epidemic in the winter of 2019/2020 was mild and lasted only 5 weeks.
New data on antimicrobial resistance in Europe New data on antimicrobial resistance (AMR) in European countries is now available in the sixth annual report of the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) netw